These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

278 related articles for article (PubMed ID: 11664318)

  • 1. The ethics of kidney transplants: physicians in controversy--who shall mete out life?
    Powledge TM
    Physicians World; 1974 p 35+; Apr 1974():. PubMed ID: 11664318
    [No Abstract]   [Full Text] [Related]  

  • 2. Equitable allocation versus best outcome: competing economic and ethical strategies in renal transplantation.
    Kiberd BA
    Ann R Coll Physicians Surg Can; 1992 Dec; 25(7):446-8. PubMed ID: 11654007
    [No Abstract]   [Full Text] [Related]  

  • 3. Transplants are common; now it's the organs that have become rare.
    Dempsey D
    N Y Times Mag; 1974 p 56-57+; 13 Oct 1974():. PubMed ID: 11663025
    [No Abstract]   [Full Text] [Related]  

  • 4. In Minn. and Mass., no transplants for the sickest?
    Bermel J
    Hastings Cent Rep; 1985 Apr; 15(2):2-3. PubMed ID: 11643772
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Issues and controversies surrounding organ donation and transplantation: the need for laws that ensure equity and optimal utility of a scarce resource.
    Khauli RB
    Suffolk Univ Law Rev; 1993; 27(4):1225-36. PubMed ID: 11657036
    [No Abstract]   [Full Text] [Related]  

  • 6. Who receives scarce medical resources? An empirical and ethical study.
    Kilner JF
    Annu Soc Christ Ethics; 1985; ():157-201. PubMed ID: 11659970
    [No Abstract]   [Full Text] [Related]  

  • 7. Rationing expensive lifesaving medical treatments.
    Mehlman MJ
    Wis L Rev; 1985; 1985(2):239-303. PubMed ID: 11658831
    [No Abstract]   [Full Text] [Related]  

  • 8. Medicare's End-Stage Renal Disease Program: its development and implications for health care policy.
    Southern HB
    Harvard J Legis; 1989; 26(1):225-62. PubMed ID: 11659153
    [No Abstract]   [Full Text] [Related]  

  • 9. Organ allocation.
    Corry RJ; Mendez R; Friedlaender GE; Russell PS; Schulman B; Opelz G
    Transplant Proc; 1988 Feb; 20(1 Suppl. 1):1011-32. PubMed ID: 11652534
    [No Abstract]   [Full Text] [Related]  

  • 10. The meaning of "The economics and ethics of alternative cadaveric organ procurement policies.
    Guttmann RD
    Yale J Regul; 1991; 8(2):453-62. PubMed ID: 11652067
    [No Abstract]   [Full Text] [Related]  

  • 11. The sale of human body parts.
    Mich Law Rev; 1974 May; 72(6):1182-264. PubMed ID: 11664350
    [No Abstract]   [Full Text] [Related]  

  • 12. Ethics and money: the case of kidney dialysis and transplantation.
    Bovbjerg RR; Held P
    Top Hosp Law; 1986 Sep; 1(4):55-70. PubMed ID: 11659069
    [No Abstract]   [Full Text] [Related]  

  • 13. Cost-benefit issues in U.S. national health legislation: the case of the End-Stage Renal Disease Program.
    Kutner NG
    Soc Probl; 1982 Oct; 30(1):51-64. PubMed ID: 11653717
    [No Abstract]   [Full Text] [Related]  

  • 14. Ethics in different cultures: the 'West'.
    Dossetor JB
    Transplant Proc; 1989 Feb; 21(1):1395-7. PubMed ID: 11650293
    [No Abstract]   [Full Text] [Related]  

  • 15. Three patients, two hearts.
    Markovitz B; May L
    Hastings Cent Rep; 1998; 28(5):20-1. PubMed ID: 11656765
    [No Abstract]   [Full Text] [Related]  

  • 16. The heart transplant dilemma.
    Evans RW
    Issues Sci Technol; 1986; 2(3):91-101. PubMed ID: 11658799
    [No Abstract]   [Full Text] [Related]  

  • 17. Allocating livers--devising a fair system.
    Steinbrook R
    N Engl J Med; 1997 Feb; 336(6):436-8. PubMed ID: 9010153
    [No Abstract]   [Full Text] [Related]  

  • 18. The chosen.
    Boly W
    Hippocrates (Sausalito); 1988; 2(3):43-51. PubMed ID: 11650163
    [No Abstract]   [Full Text] [Related]  

  • 19. Human tissues as medical treatment.
    Prottas J
    South Calif Law Rev; 1991 Nov; 65(1):445-60. PubMed ID: 11645841
    [No Abstract]   [Full Text] [Related]  

  • 20. On the possibility of "progress" in managing biomedical technologies: markets, lotteries, and rational moral standards in organ transplantation.
    Shapiro MH
    Cap Univ Law Rev; 2003; 31(1):13-69. PubMed ID: 15214334
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 14.